查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2052353

免疫腫瘤學檢測市場：依產品、技術、適應症、應用和地區分類

Immuno-Oncology Assays Market, By Product, By Technology, By Indication, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2026年，腫瘤免疫檢測市場規模將達61.9億美元，2033年將達133.5億美元。預計從2026年到2033年，該市場將以11.6%的複合年成長率成長。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 61.9億美元
歷史數據時期： 2020年至2024年 預測期： 2026年至2033年
2026年至2033年預測期間的複合年成長率： 11.60% 2033年市場規模預測： 133.5億美元

免疫腫瘤學檢測可用於分析與癌症免疫療法相關的生物分子（例如蛋白質）的表達。這些檢測有助於腫瘤譜分析、治療策略制定和免疫療法研發。它們還有助於評估免疫生物標記的表達，從而深入了解癌症與免疫系統的相互作用，並指導標靶治療。蛋白質體學、基因組學和多重檢測技術等領域的進步推動了高通量免疫腫瘤學檢測的發展。這些檢測能夠測量現有的抗腫瘤免疫反應並預測治療結果，因此已成為精準腫瘤學中不可或缺的工具。

市場動態

全球免疫腫瘤檢測市場成長的促進因素包括：對標靶癌症療法的需求不斷成長、聯合免疫療法的日益普及、製藥公司研發投入的增加以及伴隨診斷檢測的普及。然而，該市場也面臨諸多限制因素，例如免疫腫瘤檢測的高成本以及健保報銷的限制。另一方面，生物標記的持續研發以及價格合理的免疫腫瘤檢測方法的開發，為市場相關人員帶來了巨大的機會。

本次調查的主要特點

  • 本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
  • 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數對全球免疫腫瘤學檢測市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
  • 本研究涵蓋的主要公司包括 Charles River Laboratories、F. Hoffmann-La Roche Ltd、Ilumina, Inc.、Agilent Technologies, Inc.、Thermo Fisher Scientific Inc.、Merck KGaA、Invivoscribe, Inc.、QIAGEN、PerkinElmer Inc.、Sartoripatius AG、Bio-Rad Laborator. Biology、Crown Bioscience、HTG Molecular Diagnostics, Inc.、Axion BioSystems, Inc. 和 BioTherapeutics LLC。
  • 本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球免疫腫瘤學檢測市場的目標客戶群包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過分析全球免疫腫瘤檢測市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管趨勢
  • 收購與合作趨勢
  • 資金籌措及投資
  • PEST分析
  • 波特的分析

第4章 全球免疫腫瘤學檢測市場：依產品分類，2021-2033年

  • 概述
  • 消耗品
  • 軟體

第5章 全球免疫腫瘤檢測市場：依技術分類，2021-2033年

  • 概述
  • 免疫檢測
  • PCR
  • NGS
  • 流式細胞技術
  • 其他

第6章 全球免疫腫瘤學檢測市場：依適應症分類，2021-2033年

  • 概述
  • 結腸癌
  • 肺癌
  • 黑色素瘤
  • 膀胱癌
  • 其他

第7章 全球免疫腫瘤學檢測市場：依應用領域分類，2021-2033年

  • 概述
  • 臨床診斷
  • 研究與開發

第8章 全球免疫腫瘤學檢測市場：依地區分類，2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第9章 競爭情勢

  • 公司簡介
    • Charles River Laboratories
    • F. Hoffmann-La Roche Ltd
    • llumina, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Invivoscribe, Inc.
    • QIAGEN
    • PerkinElmer Inc.
    • Sartorius AG
    • Bio-Rad Laboratories, Inc.
    • Bruker Spatial Biology, Inc.
    • Nexelis
    • Reaction Biology
    • Crown Bioscience
    • HTG Molecular Diagnostics, Inc.
    • Axion BioSystems, Inc
    • BioTherapeutics LLC

第10章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2632

Immuno-Oncology Assays Market is estimated to be valued at USD 6.19 Bn in 2026 and is expected to reach USD 13.35 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 6.19 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 11.60% 2033 Value Projection: USD 13.35 Bn

Immuno-oncology assays help analyze the expression of biomolecules like proteins that are relevant for cancer immunotherapies. These assays aid in tumor profiling, treatment strategies, and development of immunotherapies. They help evaluate expression of immune biomarkers, which provides crucial insights into cancer-immune interactions and offers direction for targeted therapies. Advancements in fields like proteomics, genomic analysis, and multiplex technologies have enabled development of high-throughput immuno-oncology assays. Their ability to gauge pre-existing antitumor immune responses and predict treatment outcomes makes them integral tools in precision oncology.

Market Dynamics

The global immuno-oncology assays market growth is driven by factors such as growing demand for targeted cancer therapies, rising adoption of combinational immunotherapies, increasing R&D investments by pharmaceutical companies, and improving availability of companion diagnostic tests. However, the market faces restraints in terms of high costs associated with immuno-oncology assays and limited reimbursement for such tests. Meanwhile, ongoing research on biomarkers and development of affordable immuno-oncology assays present significant opportunities for market players.

Key Features of the Study

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global immuno-oncology assays market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this includes Charles River Laboratories, F. Hoffmann-La Roche Ltd, llumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Invivoscribe, Inc., QIAGEN, PerkinElmer Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Bruker Spatial Biology, Inc., Nexelis, Reaction Biology, Crown Bioscience, HTG Molecular Diagnostics, Inc., Axion BioSystems, Inc, and BioTherapeutics LLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global immuno-oncology assays market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immuno-oncology assays market

Market Segmentation

  • Product Insights (Revenue, USD Bn, 2021 - 2033)
  • Consumables
  • Software
  • Technology Insights (Revenue, USD Bn, 2021 - 2033)
  • Immunoassay
  • PCR
  • NGS
  • Flow Cytometry
  • Others
  • Indication Insights (Revenue, USD Bn, 2021 - 2033)
  • Colorectal Cancer
  • Lung Cancer
  • Melanoma
  • Bladder Cancer
  • Others
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Clinical Diagnostics
  • Research and Development
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Charles River Laboratories
  • F. Hoffmann-La Roche Ltd
  • llumina, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Invivoscribe, Inc.
  • QIAGEN
  • PerkinElmer Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Spatial Biology, Inc.
  • Nexelis
  • Reaction Biology
  • Crown Bioscience
  • HTG Molecular Diagnostics, Inc.
  • Axion BioSystems, Inc
  • BioTherapeutics LLC

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Technology
    • Market Snapshot, By Indication
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Immuno-Oncology Assays Market, By Product, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Consumables
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Software
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Immuno-Oncology Assays Market, By Technology, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Immunoassay
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • PCR
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • NGS
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Flow Cytometry
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Immuno-Oncology Assays Market, By Indication, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Colorectal Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Lung Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Melanoma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Bladder Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Immuno-Oncology Assays Market, By Application, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Clinical Diagnostics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Research and Development
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Immuno-Oncology Assays Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Charles River Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • llumina, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Agilent Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck KGaA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Invivoscribe, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • QIAGEN
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • PerkinElmer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sartorius AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bruker Spatial Biology, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nexelis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Reaction Biology
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Crown Bioscience
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • HTG Molecular Diagnostics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Axion BioSystems, Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BioTherapeutics LLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

10. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact